Allena Pharmaceuticals, Inc.

Home » Allena Pharmaceuticals, Inc.

IPO

Allena Pharmaceuticals, Inc.

They are a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

Symbol

ALNA

Price Range
$14.00 - $16.00

Anticipated Shares
5,000,000

Effective Date
November 2, 2017

Underwriters
Credit Suisse, Jefferies, Cowen & Company

To view the prospectus for Allena Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253